Intrinsiqs

Is Protara Therapeutics, Inc. overvalued?

Protara Therapeutics, Inc. (TARA) — key valuation metrics and fundamentals.

No verdict
Price
$3.97
Fair value
Current P/E
Normal P/E
Market cap
$223.1M
Dividend yield
0.0%
Return on equity
-41.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares TARA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.